26th
may
26 May 2026, 3:00 – 4.30 pm CEST
Unlocking the Potential of Real-World Health Data for Paediatric Clinical Research
Chair: Marek Migdal, MD, Children’s Memorial Health Institute (CMHI) and EPTRI Treasurer
Join us for an innovative webinar on in which we will explore how real-world health data can improve the design and execution of paediatric clinical trials.
Paediatric and rare disease studies often face significant challenges, including limited patient populations, complex recruitment processes, and operational burdens on families and clinical teams. During this session practical ways to address these barriers by responsibly reusing existing health data will be presented.
The webinar, designed for a broad audience, including clinicians, researchers, patient organisations, policymakers, and data specialists, will be interactive with opportunity for the participants to contribute actively to the discussion.
We hope you will join us for this insightful session and contribute to shaping a more efficient and patient-centred future for paediatric clinical research.
Speakers & Panelists
Valentina Jalby
Valentina Jalby is a patient representative, member of the TEDDY Kids Network and member of the Patient Expert Group (PEG) for the INVENTS Project
Karol Slowik
Karol Slowik is a patient representative, member of the TEDDY Kids Network – POLPEDNET YPAG and of the Patient Expert Committee (PEC) of the OrphaDev4Kids Project
Marek Migdal
Marek Migdał, MD, PhD, has been graduated from the Medical University of Warsaw in 1979. Since October 1, 1979, he is employed at the Children’s Memorial Health Institute. In December 2018, he was appointed by the Minister of Health to the position of the Director of the CMHI. In 1985-1986 and in 1990 he did research internships in France (SEPCR scholarship, then French government scholarship). In 2005-2009, he was the Head of the PICUt, then, until 2018, the Deputy head of the PICU. He is a researcher (assistant professor) at the Children’s Memorial Health Institute, author of more than 230 publications, lecturer at postgraduate courses, organizer of a number of conferences dedicated to paediatric intensive care and clinical trials in Poland. Active coordinator of international scientific cooperation. He is a member of the European Society of Pediatric and Neonatal Intensive Care (ESPNIC), in 2014-2017 elected to the Executive Board of this society as the Professional Development Committee Chair. In the years 2019-2021, vice-chair of the Ethics Section of the society. Since 2007, he is a member of the Pediatric Committee of the European Medicines Agency.
Dipak Kalra
Professor Dipak Kalra is President of The European Institute for Innovation through Health Data (www.i-hd.eu), a Professor of Health Informatics and a former London general practitioner. He plays a leading international role in Electronic Health Record R&D, including the reuse of EHRs for research. He has led the development of ISO standards on EHR interoperability, personal health records and data protection. He participates in multiple EU Horizon 2020 and IMI projects including the generation of real-world evidence in pregnancy, the governance of patient-centric clinical trials, frameworks for the design and governance of mobile health programmes, scaling up the quality, interoperability and the reuse of health data for research including inputs to the European Health Data Space, scaling up of the collection and use of health outcomes towards more value-based care, and initiatives to explain the value of clinical research to the public.
Mats Sundgren
Mats Sundgren, PhD, MSc, is a distinguished authority in Health Data Strategy, serving both industry and academia. With an impressive career spanning over 37 years in the pharmaceutical industry, Mats has made significant contributions across various domains, including Discovery, Development, Manufacturing, IT R&D, Patents, Clinical Science, and Data Science & AI. His work places him at the forefront of technological innovation in the field. He holds several key roles: Senior Industry Scientific Director and co-founder of i~HD (European Institute for Innovation through Health Data), Executive Strategic Advisor for IgniteData, which develops a system-agnostic EHR-to-EDC solution for clinical trials, and Chairman of the Board of the Research Foundation IMIT (Institute of Managing Innovation and Technology). IMIT includes prominent institutions such as Chalmers University of Technology, Royal Institute of Technology, Lund University of Technology, and Stockholm School of Business. Additionally, he serves as a Board Member of the Center for Health Governance at Gothenburg University. In July 2024, Mats assumed the role of Scientific Adviser for IOMED, a company specialising in AI-powered technology for healthcare data activation. In March 2025, he assumed the role of R&D Strategy Advisor for ZS Associates.
Peter Casteleyn
Peter Casteleyn, MSc, is a Technology Director whose mantra is enabling business to work smarter. With a career of over 24 years in the pharmaceutical industry, Peter has made significant contributions across various domains, including Commercial, Supply Chain, Development and Analytics. His work places him at the forefront of technological innovation in the field as he contributed to and triggered cross-industry collaborations in the area of bridging clinical care with clinical research. End 2024, Peter retired from Johnson & Johnson after the successful introduction of a scalable Electronic Health Records integration capability. He firmly believes in the importance of insights from data for the health care industry supported by the interoperability of health data and that industry-wide collaboration is the key to achieve this.